Research programme: psychiatric disorder therapeutics - NeuroProfile
Latest Information Update: 11 Aug 2016
At a glance
- Originator NeuroProfile
- Mechanism of Action Neuron modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Depressive disorders; Schizophrenia
Most Recent Events
- 11 Aug 2016 Early research in Schizophrenia in Germany (unspecified route)
- 11 Aug 2016 Early research in Depressive disorders in Germany (unspecified route)